Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2004
10/12/2004US6803486 Peptidomimetic; n-aminobutyl-n'-nitroguanidine derivatives
10/12/2004US6803470 2-amino-6-(2,4,5-substituted-phenyl)-pyridines
10/12/2004US6803388 Treating atherosclerosis and coronary artery diseases; stereoselective; chemical intermediates
10/12/2004US6803384 Diaminopropionic acid derivatives
10/12/2004US6803381 Carbamic acid derivatives
10/12/2004US6803378 For therapy and prophylaxis of acquired immune deficiency syndrome (aids), or arc
10/12/2004US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes
10/12/2004US6803367 Substance for inducing apoptosis
10/12/2004CA2170394C Process for conditioning substances
10/07/2004WO2004085409A2 Compounds and libraries of pyridines, pyrazines, imidazo[1,2-a]pyrazines and 1h-imidazo[4,5-b]pyrazin-2-ones and first and second medical uses thereof
10/07/2004WO2004085400A1 Substituted pyri(mi)din(thio)carboxamides used as pesticides
10/07/2004WO2004085399A1 Oxamide derivatives useful as raf-kinase inhibitors
10/07/2004WO2004085398A1 Benzene derivative having moiety of long linear conjugated structure, method for preparation thereof and liquid crystalline material
10/07/2004WO2004085388A2 Cyclic protein tyrosine kinase inhibitors
10/07/2004WO2004085385A2 Cannabinoid receptor ligands
10/07/2004WO2004085384A2 Bis-aryl sulfonamides
10/07/2004WO2004085382A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same
10/07/2004WO2004084842A2 Inhibitors of cathepsin s
10/07/2004WO2004084824A2 Biaryl substituted 6-membered heterocyles as sodium channel blockers
10/07/2004WO2004047738A3 Arylcyclopropylcarboxylic amides as potassium channel openers
10/07/2004WO2004043911A3 N-cycloalkylglycines as hiv protease inhibitors
10/07/2004WO2003068757A9 Novel pyridin- and pyrimidin-derivatives
10/07/2004US20040198987 Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates their preparation and use
10/07/2004US20040198985 Processes for preparing pesticidal intermediates
10/07/2004US20040198984 1-(3-halopyrid-2-yl)-3-substituted-5-((2,4-substituted-6-aminocarbonyl)phenylaminocarbonyl) pyrazoles insecticides
10/07/2004US20040198820 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
10/07/2004US20040198782 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration
10/07/2004US20040198780 osteoporosis; antiarthritic agents; antidiabetic aghents; Alzheimer's disease; shock; central nervous system disorders; anticancer agents
10/07/2004US20040198776 Methods for increasing leptin levels using nicotinic acid compounds
10/07/2004US20040198728 Enzyme inhibitors; antiproliferative agents; antitumor agents
10/07/2004US20040198727 Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augment the anti-cancer activity of DNA damaging treatments
10/07/2004US20040198716 Cysteine protease inhimbitors
10/07/2004US20040198712 Method for labeling phosphorylated peptides, method for selectively adsorbing phosphorylated peptides, complex compounds used in the methods, process for producing the complex compounds, and raw material compounds for the complex compounds
10/07/2004US20040198608 6-Alkyl or alkenyl-4-aminopicolinates and their use as herbicides
10/07/2004US20040197879 1,2,3,4-tetrazol-1-yl-L-alanine or 1,2,3,4-tetrazol-2-yl-L-alanine.
10/07/2004US20040197602 Electroluminescent platinum compounds and devices made with such compounds
10/07/2004DE10313683A1 Substituierte Pyri(mi)din(thio)carboxamide Substituted pyri (mi) dine (thio) carboxamides
10/07/2004CA2520009A1 Oxamide derivatives useful as raf-kinase inhibitors
10/07/2004CA2519677A1 Biaryl substituted 6-membered heterocycles as sodium channel blockers
10/07/2004CA2519401A1 Cannabinoid receptor ligands
10/07/2004CA2505590A1 Bis-aryl sulfonamides
10/07/2004CA2424644A1 Preparation of torasemide
10/06/2004EP1464327A1 Composition for dyeing human keratinous fibres comprising a fluorescent dyeing agent and a polyol, method and use
10/06/2004EP1463820A1 Method of screening compounds
10/06/2004EP1463726A2 Aromatic thioether liver x-receptor modulators
10/06/2004EP1463715A1 Novel glucagon antagonists
10/06/2004EP1463714A2 Vanilloid receptor ligands and their use in treatments
10/06/2004EP1463505A2 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
10/06/2004EP1185521B1 Substituted 1-aza-2-imino-heterocycles and their use as activators of nicotinic acetylcholine receptors
10/06/2004EP1169312B1 Glucokinase activators
10/06/2004EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents
10/06/2004EP1154993B1 Thioamide derivatives
10/06/2004EP1101755B1 Anthranilic acid derivatives
10/06/2004EP1027336B1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
10/06/2004EP0973704B1 Process for the manufacture of arylsulfonyl chloride
10/06/2004CN1535466A Programmable molecular device
10/06/2004CN1535143A Use of MGLUR 5 antagonists for treatment of pruritic conditions
10/06/2004CN1535089A Organic electro luminous device
10/06/2004CN1534023A Heterocyclic compound as dopamine-D3ligand
10/06/2004CN1534022A Phenylpyridine iridium metal complex compound and its preparation method
10/06/2004CN1169793C Process for producing bis (4-amino-1-pyridine) paraffins
10/06/2004CN1169792C Substituted vinylpyridine derivatives and drugs containing the same
10/06/2004CN1169791C Novel acetamide derivatives and protease inhibitors
10/06/2004CN1169790C Pyridine structure contained fluorine-aromatic diamine and preparation process and use thereof
10/06/2004CN1169759C Process for producing substituted aromatic compound
10/05/2004US6800728 Crosslinking and immobilizing biomolecules, drugs and synthetic polymers with a thiol or amino reactive group and hydrazino or oxyamino moieties
10/05/2004US6800660 Bis(thio-hydrazide amide) compounds; anticancer agents
10/05/2004US6800656 Tricyclic compounds and method of treating herpes virus
10/05/2004US6800652 Diaryl compounds
10/05/2004US6800651 Potentiators of glutamate receptors
10/05/2004US6800647 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3]bipyridinyl in pure crystalline form and process for synthesis
10/05/2004US6800097 For dyeing keratin fibers; hair dyes
10/05/2004CA2282834C Novel hexanoic acid derivatives
10/05/2004CA2103836C 7-(substituted)-9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines
09/2004
09/30/2004WO2004083174A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
09/30/2004WO2004083157A1 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound
09/30/2004WO2004082687A1 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors
09/30/2004WO2004082685A1 Process for the preparation of donepezil and derivatives thereof
09/30/2004WO2004082677A1 Substituted p-diaminobenzene derivatives
09/30/2004WO2004072026A3 Process for preparing pyridine-substituted amino ketal derivatives
09/30/2004WO2003072535A8 Substituted hydroxyethylamines
09/30/2004US20040192925 With formaldehyde in vapor phase
09/30/2004US20040192910 Controlling weeds; applying to plants; preemergence or postemergence herbicide
09/30/2004US20040192783 Use of B-2 bronchodilator drugs
09/30/2004US20040192744 Inhibition of Histone Deacetylase; antiproliferative; antitumor: cell differentiation; 3,5-Dimethyl-isoxazole-4-carboxylic acid (2-amino-4,5-dichloro-phenyl)-amide
09/30/2004US20040192738 Antiarrhythmia agents
09/30/2004US20040192731 For agriculture crops
09/30/2004US20040192719 Peptide deformylase inhibitors
09/30/2004US20040192712 Insecticides; for human or veterinary medicine
09/30/2004US20040192703 Preferentially substituted calcium channel blockers
09/30/2004US20040192702 Heteroaryl alkyl piperazine derivatives
09/30/2004US20040192701 Phenlypyridine carbonyl piperazine derivative
09/30/2004US20040192691 Analgesics; antiischemic agents; amyotrophic lateral sclerosis; anticonvulsants; antidepressants; local anesthetics; antiarrhythmia agents; neuropathic pain
09/30/2004US20040192681 N-acylsulfonamide apoptosis promoters
09/30/2004US20040192680 Novel amides that activate soluble guanylate cyclase
09/30/2004US20040192676 Ligands of melanocortin receptors and compositions and methods related thereto
09/30/2004US20040191959 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
09/30/2004US20040188673 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
09/30/2004US20040187225 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic diazo dye
09/30/2004DE10312073A1 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxy-pyridin-3yl)-propyl]-benzamid, dessen Verwendung als Medikament sowie dieses enthaltende pharmazeutische Zubereitungen 2- (butyl-1-sulfonylamino) -N- [1 (R) - (6-methoxy-pyridin-3-yl) propyl] benzamide, to its use as a medicament as well as pharmaceutical compositions containing this